The rate of invention may be a valuable metric for identifying strategic R&D investments to enhance knowledge creation, translational value and economic potential from NIH-supported research.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ehrlich, E. NIH's Role in Sustaining The US Economy, A 2011 Update. http://www.unitedformedicalresearch.com/wp-content/uploads/2012/07/NIHs-Role-in-Sustaining-the-US-Economy-2011.pdf (March 2012).
National Institutes of Health: Moving Research from the Bench to the Bedside. Hearing before the House Energy and Commerce Committee, Subcommittee on Health. United States House of Representatives. 108th Cong., 1st Sess. http://www.gpo.gov/fdsys/pkg/CHRG-108hhrg88429/html/CHRG-108hhrg88429.htm (10 July 2003). (Statement of Soderstrom, Yale University, on behalf of Association of University Technology Managers)
Best Practices in Transforming Research into Innovation: Creative Approaches to the Bayh-Dole Act. Hearing before the House Committee on Science, Space, and Technology, Subcommittee on Technology and Innovation. United States House of Representatives. 112th Cong., 2nd Sess. https://science.house.gov/sites/republicans.science.house.gov/files/documents/hearings/HHRG-112-%20SY-WState-TSherer-20120619.pdf (2012). (Statement of Todd T. Sherer, PhD, CLP, Association of University Technology Managers).
Families USA's Global Health Initiative. In Your Own Backyard: How NIH Funding Helps Your State's Economy http://archive-org.com/page/596772/2012-11-06/http://www.familiesusa.org/issues/global-health/publications/backyard-key-findings.html (2008).
The Federation of American Societies for Experimental Biology has curated a comprehensive list of publications that assess the economic benefits of federally funded medical research. It can be viewed at http://www.faseb.org/Policy-and-Government-Affairs/Data-Compilations/Benefits-of-Biomedical-Research/Economic-Benefits.aspx
Zeints, J.D. & Holdren, J.P. Memorandum for the Heads of Executive Departments and Agencies. M-12–15 (Washington, DC, June 2012). http://www.whitehouse.gov/sites/default/files/m-12-15.pdf
The White House. National Bioeconomy Blueprint (Washington, DC, 2012). http://www.whitehouse.gov/sites/default/files/microsites/ostp/national_bioeconomy_blueprint_april_2012.pdf
Sarewitz, D. Nature 468, 135 (2010).
Rothwell, J. et al. Patenting Prosperity: Invention and Economic Performance in the United State and its Metropolitan Areas (Brookings Institution; February 2013).
Hall, B.H., Jaffe, A. & Trajtenberg, M. Rand J. Econ. 36, 16–38 (2005).
Trajtenberg, M. Rand J. Econ. 21, 172–187 (1990).
Harhoff, D. et al. Citation Frequency and the Value of Patented Innovation. Discussion Paper FS IV 97–26, (Wissenschaftszentrum Berlin, 1997).
Hall, B.H., Thoma, G. & Torrisi, S. The Market Value of Patents and R&D: Evidence from European Firms. Working Paper 13426 (National Bureau of Economic Research, Cambridge, MA, 2007).
NIH RePORTER. http://projectreporter.nih.gov/reporter.cfm
Reporting on utilization of subject inventions, 37 CFR 401.8 (2008).
National Center for Advancing Translational Sciences (NCATS) was not included in this analysis, as many of National Center for Research Resource's research programs grants are now being administered by new institutes and centers and the core of NCATS, the Centers for Clinical and Translational Awards, have only been active since 2007.
Harhoff, D. & Reitzig, M. Int. J. Ind. Organ. 22, 443–480 (2004).
The authors declare no competing financial interests.
About this article
Cite this article
Kalutkiewicz, M., Ehman, R. Patents as proxies: NIH hubs of innovation. Nat Biotechnol 32, 536–537 (2014). https://doi.org/10.1038/nbt.2917